Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake
Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Upjohn
Mylan and Pfizer’s Upjohn unveil logo and branding for Viatris
Announcement follows Mylan shareholder approval of Mylan’s combination with Pfizer’s Upjohn. Viatris is a new company that will be…